Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020October 2020November 2020December 2020January 2021
News Every Day |

India readies colossal coronavirus vaccine rollout

India aims to begin vaccinating its 1.3 billion people against coronavirus from Saturday, a colossal and complex task compounded by safety worries, shaky infrastructure and public scepticism. In one of the world's biggest rollouts, the planet's second-most populous nation hopes to inoculate 300 million people -- equal almost to the entire US population -- by July. First to get one of two vaccines granted "emergency approval" will be 30 million health and other frontline workers, followed by around 270 million people aged over 50 or deemed high-risk all over the vast nation. About 150,000 staff in 700 districts have been specially trained, and India has held several national dry runs involving mock transportation of vaccines and dummy injections. Authorities will use the experience from holding elections in the world's biggest democracy, and from regular child immunisation programmes for polio and tuberculosis. But in an enormous, impoverished nation with often shoddy transport networks and one of the world's worst-funded healthcare systems, the undertaking is still daunting. Regular child inoculations are a "much smaller game" and vaccinating against Covid-19 will be "deeply challenging", said Satyajit Rath from the National Institute of Immunology. The two vaccines approved by India -- AstraZeneca's Covishield, made by local partner the Serum Institute, and Bharat Biotech's Covaxin -- need to be kept refrigerated at all times. A total of 29,000 cold-chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators are at the ready. - Bicycle transport - India has four "mega depots" to take delivery of the vaccines and transport them to state distribution hubs in temperature-controlled vans, but the final leg will be tough. In one recent exercise in rural Uttar Pradesh -- where summer temperatures exceed 40 degrees Celsius (105 Fahrenheit) -- a health worker was pictured transporting boxes of dummy vials on his bicycle. In Kashmir, currently being pummelled by snowstorms, databases of priority groups -- and of staff to administer the vaccines -- were still being prepared last week, officials said. During the last dry run on Friday, workers at one health centre in Bangalore had to use a cellphone hotspot to go online because their network was down. There are also concerns about the government's aim to manage the entire process digitally via its own app, CoWIN -- of which there are already several fake versions. As of Monday, it also remained unclear whether the government has yet to agree a price per jab with the Serum Institute. Tens of millions of shots are reportedly sitting at Serum's factory in the southern city of Pune waiting for an agreement before a fleet of refrigerated trucks can take them to the airport. - Sceptics - More than 150,000 Indians have died from Covid-19 and the economy is one of the worst-hit worldwide, with millions losing their livelihoods. "I look forward to getting the vaccine and living without fear and the mask all the time," migrant worker Shatrughan Sharma, 43, told AFP in the capital, New Delhi. "The last year was very tough for us." But like in other countries, there is scepticism about the vaccine, fuelled by a torrent of misinformation online. A recent survey of 18,000 people across India found that 69 percent were in no rush to get a Covid-19 shot. Public trust was not helped by Bharat Biotech's indigenous vaccine being controversially given "restricted approval" without data from Phase 3 human trials. Plans by Serum to sell the AstraZeneca jab privately to Indian individuals and firms for 1,000 rupees ($14) has also raised fears that the rich will get inoculated sooner. "There will be a long wait for poor people like me as the rich and well-off will get it first," Suresh Paswan, a rickshaw puller in Patna, in the eastern province of Bihar, told AFP. str-grk-bb-stu/leg/qan

Read also

Woman has most ‘mind-blowing orgasm’ of her life just from a man rubbing her BACK and shares exactly how you can too

There Was a ‘Sexualized Atmosphere’ at This French Label — Until Employees Spoke Up

Dutch government resigns over childcare subsidies scandal: PM Rutte

News, articles, comments, with a minute-by-minute update, now on — latest news 24/7. You can add your news instantly now — here